The $70 Million Handshake: How GTI and RYTHM Are Keeping Your Favorite Brands Moving

Big moves are happening behind the scenes for some of your favorite cannabis brands. Green Thumb Industries (GTI) and RYTHM have just shaken up their business relationship with a new $70 million annual deal. If you have ever enjoyed a jar of RYTHM flower, a pack of incredibles gummies, or some &Shine pre-rolls, this news hits home because it involves the very intellectual property that makes those products what they are.

Essentially, GTI is moving away from a traditional royalty model—where they paid a percentage of sales—to a fixed yearly fee of $70 million to use the names and recipes we all know. This includes heavy hitters like Beboe, Dogwalkers, and Doctor Solomon’s. What makes this interesting is that Ben Kovler is at the helm of both companies, effectively streamlining how these brands operate under one vision.

So, why does this matter to the average toker? For one, it shows a massive commitment to the longevity of these brands. When a company locks in a multi-million dollar deal just for the right to use a name, you can bet they are planning to keep those products on dispensary shelves for a long time. It also highlights a strategic shift toward hemp-derived THC beverages, a growing corner of the industry that makes cannabis culture more accessible to people who might prefer a drink over a smoke.

For those who follow the industry, this "loop" of loans and asset transfers between GTI and RYTHM (formerly known as Agrify) is a masterclass in navigating the complex legal landscape of cannabis. By focusing on intellectual property and hemp-based ventures, they are finding ways to grow while staying listed on major stock exchanges like the Nasdaq. For the rest of us, it just means more stability for the brands we trust and more innovative products—like those new RYTHM beverages—to look forward to. Keep an eye out for these labels next time you’re restocking; the business might be complicated, but the quality remains the priority.